PAVmed Inc. (PAVM) Stock

PAVmed Inc. (PAVM) is a Healthcare stock trading at $4.35 (as of 2026-06-18), with a market capitalization of $5.24M and a trailing P/E of -0.6. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

PAVmed Inc. is a medical device company in the United States focused on diagnostic and therapeutic technologies for conditions in the esophagus, carpal tunnel, and other clinical areas. Its product portfolio includes CarpX, EsoCheck, EsoGuard, and EsoCure, along with additional device and monitoring platforms such as Veris and implantable vascular access systems.

Valuation — source: SEC EDGAR (first-party)
Price	$4.35
Market Cap	$5.24M
P/E Ratio	-0.6
EV / EBITDA	-1.6
Price / Book	1.80
Price / Sales	530.31
DCF Value (model)	$-13.73
DCF Upside vs Price	-415.6%

Profitability & Growth — source: SEC EDGAR
Revenue (TTM)	$71000.00
Net Margin	564.8%
Return on Equity	-74.5%
Current Ratio	2.02
Revenue Growth (YoY)	175.0%
EPS Growth (YoY)	-445.3%
FCF Growth (YoY)	66.5%

Financial Health — source: SEC EDGAR
Altman Z-Score	-10.56 (distress)

Valuation vs Sector & Industry
Stock P/E	-0.6
Sector P/E (Healthcare)	20.9
Industry P/E (Medical Equipment)	31.7
vs Sector	-102.9%
vs Industry	-101.9%

Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional Holder	Two Seas Capital LP ($4.68M)
Institutional Holders Tracked	10

Company
Sector	Healthcare
Industry	Medical Equipment
CEO	Lishan Aklog
Employees	39
Country	US
IPO Date	2016-07-27

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.